The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index; 13 of the 98 sources its claims cite were checked for support.
Hypermobility spectrum disorders: A review
Open accessAbstract
It remains a clinical challenge identifying when joint hypermobility (JH) is responsible for pain. Previous nomenclature utilized terms such as (benign) joint hypermobility syndrome (JHS) but this was updated in 2017 as advances in genetics provide a basis for nearly all variants of Ehlers-Danlos syndrome (EDS) with the exception of hypermobile EDS (hEDS). New terminology describes hypermobility spectrum disorders (HSDs) as the updated term for JHS. Diagnosis of a subtype of HSDs should be considered in patients who have JH coupled with the presence of secondary musculo-skeletal manifestations (trauma, chronic pain, disturbed proprioception, and other manifestations) and at the exclusion of hEDS. Extra-articular manifestations are common. Treatment relies on management strategies for other chronic pain syndromes with a multidisciplinary approach likely optimal. Lifestyle modifications focus on weight loss and exercise. Physical therapy helps strengthen periarticular muscles, improving mobility. Pharmacologic therapies focus on judicious use of non-steroidal anti-inflammatory drugs and acetaminophen. Serotonin and norepinephrine reuptake inhibitor may help widespread pain. Avoidance of opioids remains prudent. The purpose of this review is to provide clinicians the rationale for the update in nomenclature, understand the musculoskeletal and extra-articular manifestations of the subtypes of HSDs, considerations when making the diagnosis, and treatment.
Overview
CoChat Summary
TL;DR
This narrative review summarizes the 2017 reclassification of symptomatic joint hypermobility into hypermobility spectrum disorders (HSDs), excluding hypermobile Ehlers-Danlos syndrome (hEDS), and reviews musculoskeletal and extra-articular manifestations, diagnosis, and management in adults. It emphasizes that HSDs are common, underdiagnosed, and best managed with a multidisciplinary approach focused on exercise, physical therapy, lifestyle modification, and judicious pharmacologic pain control.
Key findings
- The 2017 nosology replaced outdated terms such as benign joint hypermobility syndrome (BJHS), joint hypermobility syndrome (JHS), and EDS hypermobility type with HSDs; four subtypes are described: generalized (G-HSD), peripheral (P-HSD), localized (L-HSD), and historical (H-HSD). Diagnosis requires joint hypermobility plus secondary musculoskeletal manifestations and exclusion of hEDS, which still has no known genetic marker.
- Screening and examination: the 5-Part Questionnaire has reported sensitivity 84% and specificity 85%; for adults, a Beighton score ≥4/9 is suspicious for generalized joint hypermobility.
- Epidemiology: combined prevalence of HSDs and hEDS is 1 in 600 to 1 in 900; BJHS prevalence was about 3%–4% of the general population, affecting 3.3% of women and 0.6% of men. GJH prevalence varies widely: 32.5% in girls and 18.1% in boys under 19, 11%–12.5% or 12.5%–26% among college students, and 64.9%–72% among professional dancers.
- Extra-articular manifestations are common, including fatigue up to 84% and dysautonomia up to 75%; strongest associations include orthostasis, functional gastrointestinal disorders, and pelvic/bladder dysfunction. Treatment is multidisciplinary, with lifestyle modification, exercise, physical therapy, NSAIDs/acetaminophen, SNRIs or low-dose TCAs, and avoidance of opioids; a randomized trial of 100 adults found high-load shoulder strengthening statistically superior to low-load strengthening for self-reported function after 16 weeks.
Methods
- Narrative review focused on patients 18 years of age or older, synthesizing prior literature, the 2017 Ehlers-Danlos Society nosology, and clinical experience.
- No systematic search strategy, inclusion criteria, or formal quality appraisal is described in the text.
- The review summarizes diagnostic tools (5PQ, Beighton score), HSD subtypes, epidemiology, pathophysiology, clinical manifestations, and management strategies, including selected interventional studies.
Limitations
- The paper states that management is limited by uneven access to specialists familiar with HSDs; a Scottish survey found expertise concentrated in higher levels of care, with 80% of respondents citing lack of access to external training. It also notes that patients may struggle to trust providers after years of diagnostic delay and misdiagnosis.
- The paper states that rigorous studies evaluating lifestyle interventions are lacking, that pathophysiology and mechanisms linking HSDs to extra-articular manifestations require further investigation, and that epidemiology is hampered by changing nosology, differing measurement instruments, and heterogeneous study populations.
- Evident from the text: this is a narrative review without a described systematic search or quality appraisal, and treatment recommendations often borrow from older nomenclature or from management of other chronic pain syndromes; several cited intervention studies are small (e.g., 27, 21, 14, and 100 participants).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
10 Valid · 1 Not valid · 61 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Dysautonomia (up to 75%)”
§ Hypermobility spectrum disorders: A review > Clinical Manifestations
What the sources say
- Partly supportedcites [39] Peebles KC, Tan I, Butlin M, et al. The prevalence and impact of orthostatic intolerance in young women across the hypermobility spectrum. Am J Med Genet A. 2022;188:1761-1776. sourceExperimental — accuracy not yet measured
The Results (Symptoms of OI during HUT and active stand; page unavailable) report that 73% of participants with hEDS and G-HSD experienced orthostatic symptoms during active standing. The Discussion says symptoms of broader autonomic dysfunction were frequent, but the paper does not report that up to 75% of HSD patients had dysautonomia. The cited percentage describes symptoms in a small sample of young women, not dysautonomia prevalence across HSD patients. (LLM, conf=0.85)
- Not checked yetcites [49] Kohn A, Chang C. The relationship between hypermobile ehlersdanlos syndrome (hEDS), postural orthostatic tachycardia syndrome (POTS), and mast cell activation syndrome (MCAS). Clin Rev Allergy Immunol. 2020;58:273-297. source
- Not checked yetcites [51] Mathias CJ, Owens A, Iodice V, et al. Dysautonomia in the Ehlers-Danlos syndromes and hypermobility spectrum disorders-With a focus on the postural tachycardia syndrome. Am J Med Genet C Semin Med Genet. 2021;187:510-519. source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“With a possible onset at any age, even as late as the 6th or 7th decade of life, the onset of pain typically starts in the early to mid-teenage years.”
§ Hypermobility spectrum disorders: A review > Clinical Manifestations
What the sources say
- Could not verifycites [35] Scheper MC, de Vries JE, Verbunt J, et al. Chronic pain in hypermobility syndrome and Ehlers-Danlos syndrome (hypermobility type): it is a challenge. J Pain Res. 2015;8:591-601. sourceExperimental — accuracy not yet measured
The Introduction discusses pain in HMS/EDS-HT but gives no typical age of onset. Solution 1 discusses pain at ages 14 and 18 as outcomes in studies of joint hypermobility, not when pain typically begins. Searches for teenage pain onset and specific ages found no passage supporting early- to mid-teenage onset. (LLM, conf=0.75)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“A survey distributed to rheumatology occupational and physical therapists in Scotland found that they had expertise in the management of HSD/hEDS patients however, the expertise was concentrated in higher levels of care, making it a challenge for patients managed at a primary care level to access. [56]”
§ Hypermobility spectrum disorders: A review > Management
What the sources say
- Supportedcites [56] Dockrell DM, Berg KM, Ralston SH. Mind the gaps: therapists’ experiences of managing symptomatic hypermobility in Scotland. Rheumatol Adv Pract. 2021;5:rkab046. source
The Abstract (Results) says Scottish therapists have expertise in managing HSD/hEDS, but that it tends to be concentrated in secondary care, making access difficult for patients managed in primary care. The Conclusion likewise says specialist OT and PT services are mainly accessed through or concentrated in secondary care. (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“A different study enrolled 14 HSD/ hEDS patients in a multidisciplinary rehabilitation regimen consisting of physical training to improve aerobic capacity, muscle strength and proprioception.[64]”
§ Hypermobility spectrum disorders: A review > Management
What the sources say
- Supportedcites [64] Van Meulenbroek T, Conijn AEA, Huijnen IPJ, et al. Multidisciplinary treatment for hypermobile adolescents with chronic musculoskeletal pain. J Rehabil Med Clin Commun. 2020;3:1000033. source
Our copy states in the Abstract (Methods) that 'Fourteen adolescents with G-HSD/hEDS participated' in a multidisciplinary rehabilitation treatment whose physical training 'aims to improve aerobic capacity, muscle strength and propriocepsis', and METHODS > Participants confirms 14 adolescents with G-HSD/hEDS completed MRT (inclusion: chronic musculoskeletal pain, age 12-21, Beighton score criteria). Table I and METHODS > Multi-rehabilitation treatment give the same physical-training targets (aerobic capacity, muscle strength, core stability, propriocepsis; 8 weeks, 2 h 2x/week). The only nuance is that the regimen described in the source also contained an exposure-in-vivo (cognitive-behavioural) module alongside the physical training, and the participants were specifically adolescents with chronic musculoskeletal pain; nothing in the claim conflicts with the source. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
None of the sources cited for this claim have been checked yet.
In the paper
“Fear of provoking pain and sustaining injury potentially leads to decreased levels of physical activity, hastening deconditioning and exercise intolerance.[8,33]”
§ Hypermobility spectrum disorders: A review > Pathophysiology
What the sources say
- Not checked yetcites [8] Kumar B, Lenert P. Joint hypermobility syndrome: recognizing a commonly overlooked cause of chronic pain. Am J Med. 2017;130:640-647. source
- Not checked yetcites [33] Rombaut L, Malfait F, De Wandele I, et al. Muscle-tendon tissue properties in the hypermobility type of Ehlers-Danlos syndrome. Arthritis Care Res (Hoboken). 2012;64:766-772 source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
29 more claims
Create a free account to see all 83 claims and to verify the 85 references still open.
- Probably not a substantial claim. 22
- It may state two separate claims as one. 34
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“EDS is rare or ultra‐rare for several subtypes, but hEDS and HSD are much more common [7, 8].”
From Meta-Analysis: Chronic Gastrointestinal Symptoms and Comorbidities in Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders (2026) · cites this paper as [7]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Hypermobility spectrum disorders: A review > Pathophysiology
“A 2010 meta-analysis of 18 studies concluded that there is an increased risk of knee injury but not of the ankle.[27]”
§ Hypermobility spectrum disorders: A review > References
“27. Smith TO Jerman E Easton V et al Do people with benign joint hypermobility syndrome (BJHS) have reduced joint proprioception? A systematic review and meta-analysis Rheumatol Int 2013 33 2709 - 2716”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Hypermobility spectrum disorders: A review > Pathophysiology
“Two studies comparing patients with asymptomatic GJH with BJHS found patients with BJHS tended toward decreased joint momenta in the lower extremities, necessitating a greater force to maintain equilibrium.[30,31]”
§ Hypermobility spectrum disorders: A review > References
“30. Chiarelli N Carini G Zoppi N et al Transcriptome-wide expression profiling in skin fibroblasts of patients with joint hypermobility syndrome/Ehlers-Danlos Syndrome Hypermobility Type PLoS One 2016 11 e0161347”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Place hands flat on the floor without bending the knees (“palm the floor”) | 1 | 1 | | TOTAL SCORE (maximum of 9 points) | | |”
§ Hypermobility spectrum disorders: A review > Defining & Identifying Joint Hypermobility
Reported 9 · recomputed 10
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Hypermobility spectrum disorders: A review > Pathophysiology
“Of note, these conclusions have been refuted by other studies, with a systematic review questioning the clinical relevance of differences in gait and the effect that it has in the musculoskeletal pain of BJHS.[32]”
§ Hypermobility spectrum disorders: A review > References
“32. Simonsen EB Tegner H Alkjaer T et al Gait analysis of adults with generalised joint hypermobility Clin Biomech 2012 27 573 - 577 10.1016/j.clinbiomech.2012.01.008 22364778”
Citations
Cites
The 2017 international classification of the Ehlers–Danlos syndromes
Malfait, F., Francomano, C., Byers, P., Belmont, J., Berglund, B., Black, J., Bloom, L., Bowen, J. M., Brady, A. F., Burrows, N. P., et al. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31552 · Cited by 1,936 · cited 6×
“05.[23] Cutaneous findings inconsistent with HSDs are unusually soft or velvety skin, mild skin hyperextensibility, piezogenic papules of the heel, and atrophic scarring.”
BackgroundMethodInfluential(2000) · PubMed · Cited by 738
A framework for the classification of joint hypermobility and related conditions
Castori, M., Tinkle, B., Levy, H., Grahame, R., Malfait, F., & Hakim, A. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31539 · Cited by 602 · cited 18×
“With the elimination of the term BJHS in 2017, figures are now used to describe the combined prevalence of HSD and hEDS.”
BackgroundInfluentialKirk, J. A., Ansell, B. M., & Bywaters, E. G. (1967) · Annals of the Rheumatic Diseases · doi:10.1136/ard.26.5.419 · Cited by 468
(2007) · PubMed · Cited by 356
Hakim, A., & Grahame, R. (2003) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2003.tb10455.x · Cited by 312 · cited 3×
“[10] Reported sensitivity and specificity for the 5PQ is 84% and 85% respectively.[8,10] Physical examination may also identify JH.”
BackgroundMethodTinkle, B. T., Bird, H. A., Grahame, R., Lavallee, M., Levy, H. P., & Sillence, D. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33070 · Cited by 290 · cited 2×
“This work was the culmination of years of expert opinion[5] and a familial study demonstrating co-segregation of these two disorders in pedigrees with multiple affected members fitting criteria for both.”
BackgroundMethodDemmler, J. C., Atkinson, M. D., Reinhold, E. J., Choy, E., Lyons, R. A., & Brophy, S. T. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031365 · Cited by 271
Juul‐Kristensen, B., Schmedling, K., Rombaut, L., Lund, H., & Engelbert, R. H. H. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31540 · Cited by 229
Pain management in the Ehlers–Danlos syndromes
Chopra, P., Tinkle, B., Hamonet, C., Brock, I., Gompel, A., Bulbena, A., & Francomano, C. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31554 · Cited by 209
Research works printed but not linked: 1
- Bravo J, Sanhueza FG, Hakim AJ. Cardiovascular autonomic dysfunction and chronic fatigue in fibromyalgia and joint hypermobility syndrome. In: Hypermobility, Fibromyalgia and Chronic Pain. London: Churchill Livingstone. Elsevier, 2010:69-82.
Cited by
Daylor, V., Griggs, M., Weintraub, A., Byrd, R. L., Petrucci, T., Huff, M. L., Byerly, K., Fenner, R., Severance, S., Griggs, C., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14165636 · Cited by 35
“Patients who exhibit symptomatic joint hypermobility but do not meet the full diagnostic criteria for hEDS are often labeled with hypermobility spectrum disorders (HSD), a classification that remains poorly defined and inconsistently applied [4].”
Ritelli, M., Chiarelli, N., Cinquina, V., Bertini, V., Piantoni, S., Caproli, A., Pina, S. E. L. D., Franceschini, F., Zarattini, G., Gandy, W., et al. (2024) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63857 · Cited by 28
“…ambiguity not only places a substantial burden on healthcare practitioners but also significantly impacts patients, leading to prolonged diagnostic journeys, misdiagnosis, and potentially harmful delays in appropriate management (Anderson and Lane 2021; Carroll 2023; Halverson et al. 2021).”
InfluentialVentral Rectopexy: An International Expert Panel Consensus and Review of Contemporary Literature
Perry, W., Christensen, P., Collinson, R. J., Cornish, J. A., D’Hoore, A., Gurland, B., Mellgren, A. F., Ratto, C., Ris, F., Stevenson, A. R. L., et al. (2025) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000003656 · Cited by 26
“88 Marfan syndrome, which affects fibrillin production, a different connective tissue component to the above, can also be included under the CTDs for this discussion.”
Ribeiro, J. A. D. S., Gomes, G., Aldred, A., Desuó, I. C., & Giacomini, L. A. (2024) · The Yale Journal of Biology and Medicine · doi:10.59249/wgrs1619 · Cited by 19
“The hypermobile syndromes, whether hEDs or HSD, constitute a group of complex conditions with multifac - torial origins that remain poorly understood from both biomechanical and genomic-molecular perspectives [45].”
BackgroundNeto, N. S. R., Pereira, I. A., Sztajnbok, F., & Azevedo, V. F. (2024) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-024-00373-z · Cited by 17
“…relationship with collagen disorders since they can be identified in distinct genetic disorders, for example: Down syndrome (trisomy 21), homocystinuria (cystathionine β-synthase deficiency) and mucopolyssacaridosis type VI (lysosomal hydrolase N-acetylgalactosamine 4-sulfatase deficiency) [16–18].”
Background
Metadata
- Authors
- Carroll, M. B.
- Affiliations
- Singing River Health System (US)
- Corresponding author
- Carroll, Matthew B
- ORCID
- Carroll, Matthew B
- Venue
- Rheumatology and Immunology Research
- Publisher
- Walter de Gruyter GmbH
- Published
- 2023-06-01
- Volume
- 4
- Issue
- 2
- Pages
- 60-68
- ISSN
- 2719-4523 (ISSN-L)
- PMC
- PMC10457547
- OpenAlex
- W4385147201
- Cited by
- 45
- References
- 63
- Citations by year
- 2026: 14 · 2025: 18 · 2024: 13
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Rheumatology and Immunology Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Keywords
- hypermobility spectrum disorders, joint hypermobility, Ehlers-Danlos syndrome, hypermobile Ehlers-Danlos syndrome, benign joint hypermobility syndrome, nomenclatural changes, chronic musculoskeletal pain, extra-articular manifestations, proprioception, multidisciplinary management, physiotherapy, physical activity, weight loss, nonsteroidal anti-inflammatory drugs, paracetamol, serotonin-norepinephrine reuptake inhibitors, opioid avoidance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypermobility spectrum disorders: A review. https://app.cochat.ai/papers/10.2478/rir-2023-0010
- The paper
- Carroll, M. B. (2023). Hypermobility spectrum disorders: A review. Rheumatology and Immunology Research. https://doi.org/10.2478/rir-2023-0010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.